ERIN COKELEY: Open Payments
NPI 1003401431 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 26 payments from 8 companies in 2025. Trend: 2023 $75 · 2024 $267 · 2025 $457
Food & beverage: $358Education: $99
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 13 | $152 |
| Astellas Pharma US Inc | 5 | $145 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Dexcom, Inc. | 1 | $22 |
| Organon LLC | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: ZURZUVAE, MYFEMBREE, Veozah, Dexcom G6 Transmitter, NEXPLANON, LILETTA, SLYND.
Industry payments across KS — which companies pay providers there.
